Comparing Minimally Invasive Treatments for Pilonidal Disease: LA POPA Trial (Laser And Pit-picking OR Pit-picking Alone)

Trial Title: Comparing Minimally Invasive Treatments for Pilonidal Disease: LA POPA Trial (Laser And Pit-picking OR Pit-picking Alone)

NCT ID: NCT06140199

Condition: Pilonidal Sinus
Pilonidal Disease
Pilonidal Sinus of Natal Cleft
Pilonidal Disease of Natal Cleft
Pilonidal Sinus Without Abscess

Conditions: Official terms:
Pilonidal Sinus

Conditions: Keywords:
Pit-picking
Laser-assisted therapy
SiLaC
Minimally invasive surgery

Study type: Interventional

Study phase: N/A

Overall status: Not yet recruiting

Study design:

Allocation: Randomized

Intervention model: Parallel Assignment

Intervention model description: Multicentre, single-blinded, randomised, controlled, superiority trial. It

Primary purpose: Treatment

Masking: Single (Outcomes Assessor)

Masking description: Only the outcome assessor is blinded.

Intervention:

Intervention type: Procedure
Intervention name: Pit-picking surgery
Description: Patients are placed in left-side position. After shaving, cleaning and scrubbing of the skin with alcoholic chlorhexidine, double strong tape is placed on the right buttock in order to increase exposure. Local anaesthesia is administered before incision with 20 ml xylocaine or lidocaine 1-2%. In principle, all sinusoidal pits are cut out with a margin of at least 1 mm with a biopsy core punch (4 mm, 6 mm or 8 mm depending on pit size) or an oval excision of the pits is performed. Hair and debris is removed from the sinus tracts with a small surgical spoon or mosquito clamp. Rigorous de-epithelialisation of the underlying sinus is performed with the spoon through every pit, whilst removing even more debris and hairs. At the end of the procedure a debris washout is performed with saline solution, the wounds are left open for secondary healing and sterile dressings are applied.
Arm group label: Pit-picking surgery

Intervention type: Procedure
Intervention name: Pit-picking surgery with Sinus Laser assisted Closure
Description: The pit picking procedure is described above. Subsequently, a radial diode laser probe at 1470 nm wavelength is used for delivering homogeneous (360 degrees) energy to the surrounding epithelium. The laser energy is 13 Joule, given continuously. First, a 'preparatory laser treatment' is performed to extract any missed hairs or debris, after which the sinus tracts are cleansed with a surgical spoon again. During the following definitive procedure, the probe is withdrawn at an approximate speed of 1 cm per three seconds, causing the small sinus tracts to shrink and close. Large sinus tracts remain open because very large sinus tracts or cavities cannot be closed with the 3mm laser fibre. The injury to the endothelium will cause granulation and create oedema for collapsing of the tract. The remaining open wounds are left open for secondary healing and sterile dressings are applied.
Arm group label: Pit-picking surgery with Sinus Laser assisted Closure

Summary: The goal of this randomized clinical trial is to establish the efficacy of 'pit picking with laser therapy' versus 'pit picking alone' on both short and long-term outcomes in patients of 12 years and older with primary pilonidal sinus disease. The main questions it aims to answer are: - The overall success rate of treatment which is defined as: closure of all pits at 12 months of follow-up. - Secondary endpoints: succes rat eof treatment during long-term follow-up, wound closure time, pain scores, complication rate, work rehabilitation, time to return to daily activities, quality of life, persisting complaints, patient satisfaction, costs and the need for secondary or revision surgery. Participants will allocated to pit picking alone or combined with lasertherapy. The extra burden for participating patients is expected to be minimal to moderate. Participants will have two extra hospital visits in casethey are enrolled in our study: 6 and 12 months after enrolment. Postoperatively the normal scheme of follow up appointments wil be used: 2 and 6 weeks after treatment at the outpatient clinic of the treating surgeon. A telephone appointment with the researcher will be scheduled 4 weeks after treatment. Patients are asked to complete questionnaires at various time points, which will be sentto them by email and will take approximately 5-10 minutes each time. The content includes general and disease specific Quality of Life (QoL) questionnaires. The investigators do not expect any extra adverse reactions or events in respect to participation in the study because both procedures are considered standard of care in the participating clinics. However, because both interventions are surgical procedures a small percentage of adverse events or postoperative complications can be expected.

Criteria for eligibility:
Criteria:
Inclusion Criteria: - All patients aged 12 years and older who present with primary pilonidal sinus disease; Type 1b and 3 of the Dutch staging system - Obtained written informed consent by the patient and/or legal representative/parent - Sufficient understanding of the Dutch written language (reading and writing) - Eligible for questionnaires sent by e-mail Exclusion Criteria: - Asymptomatic (Type 1a), recurrent (Type 4; except those patients who only have had drainage of their abscess and no other surgical treatment), or chronic wounds (hypergranulating) after PSD surgery (Type 5) of the Dutch staging system - Patients with known underlying or concomitant medical conditions that may interfere with normal wound healing (e.g. systemic skin and connective tissue diseases, any kind of congenital defect of metabolism including insulin-dependent diabetes mellitus, Cushing syndrome or disease, scurvy, chronic hypothyroidism, congenital or acquired immunosuppressive condition, chronic renal failure, or chronic hepatic dysfunction (Child-Pugh class B or C), severe malnutrition, or other concomitant illness which, in the opinion of the investigator, has the potential to significantly delay wound healing) - Severe drug abuse (and therefore protocol deviation can be expected) - Patients expected not to comply with the study protocol (including patients with severe cognitive dysfunction/impairment and severe psychiatric disorders) - Patients with insufficient knowledge of the Dutch written language who are thus unable to answer the questionnaires - Patients that are unable or not willing to give full informed consent

Gender: All

Minimum age: 12 Years

Maximum age: N/A

Healthy volunteers: No

Start date: August 28, 2024

Completion date: May 2032

Lead sponsor:
Agency: dr. IJM Han-Geurts
Agency class: Other

Collaborator:
Agency: Flevoziekenhuis
Agency class: Other

Collaborator:
Agency: Proctos Kliniek
Agency class: Other

Collaborator:
Agency: Sint Jans Gasthuis Weert
Agency class: Other

Collaborator:
Agency: UMC Utrecht
Agency class: Other

Collaborator:
Agency: Ziekenhuis Amstelland
Agency class: Other

Collaborator:
Agency: Treant ziekenhuis
Agency class: Other

Collaborator:
Agency: Albert Schweitzer Hospital
Agency class: Other

Source: Proctos Kliniek

Record processing date: ClinicalTrials.gov processed this data on November 12, 2024

Source: ClinicalTrials.gov page: https://clinicaltrials.gov/ct2/show/NCT06140199